COVID Crisis: Remdesivir Hits Drug Regulator Hurdle In India
New Delhi: Even as COVID-19 cases are soaring in India, patients in the country are still to get Remdesivir, an experimental drug which has shown promise in treatment of coronavirus in other countries.
This is because the Drugs Controller…